BiotechTube
Home/Mondego Bio/Ruben Karapetyan
RK

Ruben Karapetyan

Head of Non-Clinical Development

Mondego Bio

Roles

Head of Non-Clinical DevelopmentatMondego Bio
Head of DevelopmentatMwyngil Therapeutics

Therapeutic Areas

OncologyImmunology

Mondego Bio Pipeline

DrugIndicationPhase
PTPN2 Inhibitor (ZE00-0388 / Clinical Candidate)Cancer Immunotherapy (specific indications not disclosed)Pre-clinical

Leadership Team at Mondego Bio

NS
Nikolay Savchuk
Chief Executive Officer
AP
Alexei Pushechnikov
Head of Medicinal Chemistry
RS
Rita Santos
External Outreach Director
ID
Iain Dukes
Chairman of the Board
View full Mondego Bio profile